Discontinue use if paradoxical bronchospasm occurs. Not to be used for initial management, 1st treatment & regular prophylaxis of asthma. Not to be initiated during exacerbation or in patients w/ significantly worsening or acutely deteriorating asthma. Cardiac arrhythmias especially 3rd degree AV block & tachyarrhythmias; idiopathic subvalvular aortic stenosis, hypertrophic obstructive cardiomyopathy, severe heart disease particularly acute MI, ischaemic heart disease, CHF, occlusive vascular diseases particularly arteriosclerosis, arterial HTN & aneurysm; known or suspected QTc interval. Thyrotoxicosis, DM, phaeochromocytoma & untreated hypokalaemia. Unstable asthma; active or quiescent pulmonary TB, fungal & viral airway infections. Cushing's syndrome, Cushingoid features, adrenal suppression decreased bone mineral density, cataract, glaucoma, psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression. Risk of oropharyngeal Candida infections. Transferring patients from previous systemic steroid therapy. Monitor serum K & blood glucose levels. Not to be administered for at least 12 hr prior to anaesth. Avoid abrupt w/drawal. High-dose & prolonged use. Concomitant use w/ xanthine derivatives, steroids & diuretics. Not recommended during pregnancy. Lactation. Growth retardation in childn & adolescents. Not recommended in childn & adolescents <18 yr.